Cargando…
Identification and characterization of Nanobodies targeting the EphA4 receptor
The ephrin receptor A4 (EphA4) is one of the receptors in the ephrin system that plays a pivotal role in a variety of cell-cell interactions, mostly studied during development. In addition, EphA4 has been found to play a role in cancer biology as well as in the pathogenesis of several neurological d...
Autores principales: | Schoonaert, Lies, Rué, Laura, Roucourt, Bart, Timmers, Mieke, Little, Susan, Chávez-Gutiérrez, Lucía, Dewilde, Maarten, Joyce, Peter, Curnock, Adam, Weber, Peter, Haustraete, Jurgen, Hassanzadeh-Ghassabeh, Gholamreza, De Strooper, Bart, Van Den Bosch, Ludo, Van Damme, Philip, Lemmens, Robin, Robberecht, Wim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500810/ https://www.ncbi.nlm.nih.gov/pubmed/28526745 http://dx.doi.org/10.1074/jbc.M116.774141 |
Ejemplares similares
-
Lowering EphA4 Does Not Ameliorate Disease in a Mouse Model for Severe Spinal Muscular Atrophy
por: Poppe, Lindsay, et al.
Publicado: (2019) -
Reducing EphA4 before disease onset does not affect survival in a mouse model of Amyotrophic Lateral Sclerosis
por: Rué, Laura, et al.
Publicado: (2019) -
EphA4 loss improves social memory performance and alters dendritic spine morphology without changes in amyloid pathology in a mouse model of Alzheimer’s disease
por: Poppe, Lindsay, et al.
Publicado: (2019) -
Environmental enrichment during the chronic phase after experimental stroke promotes functional recovery without synergistic effects of EphA4 targeted therapy
por: de Boer, Antina, et al.
Publicado: (2020) -
Novel Human/Non-Human Primate Cross-Reactive Anti-Transferrin Receptor Nanobodies for Brain Delivery of Biologics
por: Rué, Laura, et al.
Publicado: (2023)